Related Experiment Video

Updated: Oct 11, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis

J M Mayer1, V J Laine, A Gezgin

  • 1Department of General Surgery, University of Ulm, Germany.

The European Journal of Surgery = Acta Chirurgica
|October 18, 2000
PubMed
Abstract

Insights

Two immunomodulatory drugs, FK506 (tacrolimus) and OKT3 (Orthoclone), significantly reduced early inflammatory complications and organ damage in experimental acute pancreatitis in mice.

Area of Science:

  • Immunology
  • Gastroenterology
  • Transplantation Medicine

Background:

  • Acute pancreatitis is a severe inflammatory condition with significant morbidity and mortality.
  • Early inflammatory complications, including multi-organ dysfunction, are a major challenge in managing acute pancreatitis.
  • Immunomodulatory drugs like FK506 and OKT3 are used in organ transplantation but their role in pancreatitis is less understood.

Purpose of the Study:

  • To investigate the efficacy of FK506 (tacrolimus) and OKT3 (Orthoclone) in mitigating early inflammatory complications of experimental acute pancreatitis.
  • To assess the impact of these immunomodulatory agents on pancreatic and pulmonary damage, and systemic inflammatory markers.

Main Methods:

  • A laboratory study involving 36 Balb/c mice.
  • Acute pancreatitis was induced using cerulein injections.
  • Mice received either FK506, OKT3, or saline (control) intraperitoneally.
  • Evaluated serum amylase, IL-6, histological damage, apoptosis, and myeloperoxidase activity.

Main Results:

  • Both FK506 and OKT3 treatments reduced pancreatic histological scores, apoptosis, and inflammatory infiltration compared to controls.
  • Pulmonary damage and myeloperoxidase activity were significantly lower in the FK506 and OKT3 groups.
  • Hemoconcentration, indicated by packed cell volume, was reduced by the immunomodulatory drugs.

Conclusions:

  • Single therapeutic doses of FK506 and OKT3 effectively reduced the early severity of experimental acute pancreatitis in mice.
  • These drugs also mitigated associated pulmonary damage and hemoconcentration.
  • FK506 and OKT3 show potential as therapeutic agents for preventing early complications of acute pancreatitis.

More Related Videos

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

Related Concept Videos

Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...